University of Michigan

Luz Blanco

James R Baker, Jr

Paul E Makidon

Anna U Bielinska

Jessica Ann Knowlton

Tarek Hamouda

Stewart C Wang

John LiPuma

Mark R Hemmila

Jeffery V Groom, Ii

Nicholas Mank

The present invention relates to therapeutic nanoemulsion compositions and to methods of utilizing the same. In particular, nanoemulsion compositions are described herein that find use in the treatment and/or prevention of infection (e.g., respiratory infection (e.g., associated with cystic fibrosis)), in burn wound management, and in immunogenic compositions (e.g., comprising aantigen) that generate an effective immune response (e.g., against a bacterial species of the genus) in a subject administered the immunogenic composition. Compositions and methods of the present invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine), industrial, and research applications.

Nanoemulsion therapeutic compositions and methods of using the same

The present invention provides methods and compositions for the stimulation of immune responses. Specifically, the present invention provides methods of inducing an immune response against one or a plurality of pathogens (e.g., vaccinia virus, H5N1 influenza virus,, Hepatitis B, and/or HIV, etc.) in a subject (e.g., a human subject) and compositions useful in such methods (e.g., immunogenic composition comprising nanoemulsion and one or a plurality of pathogens (e.g., inactivated by the nanoemulsion) and/or pathogen products and/or pathogen components). Compositions and methods of the present invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine (e.g., vaccination)) and research applications.

Multivalent nanoemulsion vaccines

Growing community of inventors

Ann Arbor, MI, United States of America

Luz Blanco